Prevalence of osteonecrosis and associated risk factors in children before allogeneic BMT.
Osteonecrosis (ON) is a debilitating long-term complication of allogeneic BMT (allo-BMT), but may begin before allo-BMT in some children because of their primary disease treatment. Therefore, to estimate the prevalence and associated risk factors for ON before allo-BMT, we conducted a retrospective analysis of magnetic resonance (MR) studies of 118 children who underwent first allo-BMT at our institution between December 2000 and September 2007. Of the 118 consecutive patients, 107 (90.7%) underwent prospective MR studies irrespective of symptoms (69 males; median age at allo-BMT 12.9 years), and 11 underwent MR studies for symptoms. Among the 107 who had prospective imaging, 23 (21.5%) had ON; nearly 50% had at least 30% epiphyseal involvement. Knees were more frequently involved than were hips; severity of ON was greater in hips. ON prevalence before allo-BMT was 23.72% when all 118 patients were included in the denominator. Risk factor analysis, limited to MR studies performed irrespective of symptoms, revealed female gender (P=0.049) and age 10 years at the time of MR study (P=0.03) as significant risk factors, and primary diagnosis of lymphoid malignancies and aplastic anemia trended toward significance. ON before allo-BMT is a common occurrence in children.
Sharma
S
S
Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA.
Yang
S
S
Rochester
R
R
Britton
L
L
Leung
W H
WH
Yang
J
J
Neel
M D
MD
Ness
K K
KK
Kaste
S C
SC
D000293:Adolescent; D000367:Age Factors; D000741:Anemia, Aplastic / Q000628:therapy; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D005260:Female; D006615:Hip; D006801:Humans; D007223:Infant; D007717:Knee; D007945:Leukemia, Lymphoid / Q000628:therapy; D008279:Magnetic Resonance Imaging; D008297:Male; D010020:Osteonecrosis / Q000453:epidemiology*; D015995:Prevalence; D012189:Retrospective Studies; D012307:Risk Factors; D012737:Sex Factors; D013997:Time Factors; D014184:Transplantation, Homologous; D055815:Young Adult
Blood. 1995 Oct 15;86(8):3247-56
7579422
AJR Am J Roentgenol. 2006 Feb;186(2):477-82
16423956
Leuk Lymphoma. 2000 May;37(5-6):635-7
11042527
Med Pediatr Oncol. 1993;21(9):655-60
8412999
Transplantation. 2004 Oct 15;78(7):1055-63
15480174
J Clin Oncol. 2007 Apr 20;25(12):1525-31
17442995
J Pediatr Hematol Oncol. 2008 Nov;30(11):798-802
18989155
Clin Orthop Relat Res. 2008 Feb;466(2):287-93
18196408
Am J Med. 1990 Dec;89(6):733-8
2252042
J Clin Oncol. 2000 Sep 15;18(18):3262-72
10986059
J Bone Joint Surg Br. 1991 Jan;73(1):68-72
1991778
Joint Bone Spine. 2002 May;69(3):262-9
12102272
Br J Haematol. 1993 Aug;84(4):731-5
8217834
Haematologica. 2003 Jul;88(7):747-53
12857552
J Bone Joint Surg Am. 2008 Mar;90(3):477-84
18310696
J Bone Joint Surg Am. 1991 Jan;73(1):81-92
1985998
Med Pediatr Oncol. 1999 Jan;32(1):11-7
9917747
Br J Haematol. 1997 Jun;97(4):865-70
9217190
Endocrinol Metab Clin North Am. 1991 Mar;20(1):1-14
2029881
J Pediatr Hematol Oncol. 2005 May;27(5):259-63
15891560
J Clin Oncol. 2008 Jun 20;26(18):3038-45
18565890
J Clin Oncol. 2004 Oct 1;22(19):3930-6
15459215
Cancer. 2000 Oct 1;89(7):1482-9
11013361
Haematologica. 2006 Aug;91(8):1096-9
16885050
Acta Haematol. 1996;96(2):88-91
8701707
J Bone Joint Surg Am. 2008 Nov;90 Suppl 4:175-87
18984729
Niger Postgrad Med J. 2007 Sep;14(3):217-20
17767206
J Korean Med Sci. 2002 Dec;17(6):806-10
12483006
Pediatr Transplant. 2003;7 Suppl 3:71-5
12603697
Child Dev. 2009 Mar-Apr;80(2):327-37
19466995
Br J Haematol. 1994 Mar;86(3):624-8
8043445
Bone Marrow Transplant. 2004 Feb;33(4):435-41
14716354
Drug Saf. 2008;31(5):359-71
18422377
Clin Orthop Relat Res. 2004 Dec;(429):124-30
15577476
N Engl J Med. 1991 Nov 21;325(21):1476-81
1944426
J Clin Oncol. 2007 Apr 20;25(12):1498-504
17442991
J Bone Joint Surg Am. 2006 Nov;88 Suppl 3:126-30
17079378